J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Celldex Announces Additions To The Board Of Directors And Senior Management Team June 15, 2017 Omeros Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week June 28, 2017 Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial July 4, 2017
Omeros Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week June 28, 2017